Comparative study between 18F-FDG PET scan and conventional CT in assessment of non-small cell lung cancer patients after treatment
Keywords:
Non-small cell lung cancer (NSCLC), Positron Emission Tomography (PET), Computed tomography (CT)Abstract
Background: Lung cancer is one of the most common malignancies worldwide. Hence, timely diagnosis and accurate staging of the carcinoma as well as strict follow up is critical for better prognosis. Imaging studies play a key role in post-treatment follow up of patients with lung cancer. Positron emission tomography (PET) scanning has developed as an important tool in the multi-disciplinary management of lung cancer. The combination of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) has a great impact on the diagnosis, staging, and hence on the follow up of lung cancer patients compared to conventional CT study only. Methods: A retrospective comparative study conducted on 15 patients histopathologically proven to have NSCLC. Conclusion: 18F-FDG PET scan had a superior role in monitoring tumor turn over in case of no appreciable time interval changes in its size according to the CT.
Downloads
References
Shah D, Shastri M, Patel D, et al.(2017) Diagnosis and staging of lung carcinoma with CT scan and its histopathological correlation. International Journal of Research in Medical Sciences; 6:2346-2352.
Zappa C and Mousa SA. (2016) Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res.; 5(3): 288–300.
Sheikhbahaei S, Mena E, Yanamadala A, et al. (2017) The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer. AJR; 208:420–433.
Chao F and Zhang H. (2012) PET/CT in the Staging of the Non-Small-Cell Lung Cancer. Journal of Biomedicine and Biotechnology; 1-8.
Dane B, Grechushkin V, Plank A, et al.( 2013) PET/CT vs. non-contrast CT alone for surveillance 1-year post lobectomy for stage I non-small-cell lung cancer. Am J Nucl Med Mol Imaging; 3(5):408-416.
Tawfik M.M.H., Monib A.M., Yassin A., et al. (2016) Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma. Egyptian Journal of Radiology and Nuclear Medicine; 51:82.
Ding Q, Cheng X, Yang L, et al (2014) PET/CT evaluation of response to chemotherapy in non-small cell lung cancer: PET response criteria in solid tumors (PERCIST) versus response evaluation criteria in solid tumors (RECIST). J Thorac Dis; 6:677–683
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
